ACM
TECH icon

Aster Capital Management’s Bio-Techne TECH Stock Holding History

Aster Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,077
Closed -$55.4K – 1359
2025
Q2 		$55.4K Buy
1,077
+627
+139% +$31.5K 0.01% 593
2025
Q1 		$27.8K Buy
450
+263
+141% +$17.8K 0.01% 941
2024
Q4 		$13.5K Buy
+187
New +$13.7K 0.01% 700

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Aster Capital Management's TECH Position: Q3 2025 in Review

Aster Capital Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 1,077 shares — an estimated $55.4K sold.

Aster Capital Management first reported a position in TECH in Q4 2024 and held it in 3 quarters. The position peaked at $55.4K in Q2 2025. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Aster Capital Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Aster Capital Management sold 1,077 Bio-Techne shares in Q3 2025, an estimated $55.4K.
  • Aster Capital Management first reported a position in Bio-Techne in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's Bio-Techne position peaked at $55.4K in Q2 2025.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Aster Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.